soul trial oral semaglutide cardiovascular outcomes nejm 2025 results A emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with obesity and diabetes. Link SOUL Trial Shows Oral Semaglutide

But in addition to the oral compound, the branded medications, the personalized GLP-1 doses, which augment the commercially available dosages for patients that need it as well as off-patent GLP-1s like liraglutide, I think we believe the combination of that portfolio, allows customers and providers a really robust range of offerings that we think is very durable

They signal fullness, slow gastric emptying, and reduce cravingsmaking it easier to maintain a calorie deficit without constant hunger

Ergins SugarMD Advanced Glucose Support products after FDA laboratory analysis found the supplement to contain glyburide and metformin

People dont know, especially Bri (00:21:10):That true

Gently pat into skin to increase absorption.